Key result
Thoracotomy and metastasectomy linked to ~12-month longer median survival versus chemotherapy in sarcoma lung metastases.
Authors
Loading...
May support metastasectomy consideration in select cases; hypothesis-generating and requires randomized confirmation before practice change.
Cohort (n=77)
Absolute Event Rate: 26% vs 14%
Mentzer et al. (1993) conducted a cohort in Sarcoma metastatic to the lung (n=77). Thoracotomy and metastasectomy vs. Chemotherapy alone was evaluated on Median survival (months). Thoracotomy and metastasectomy was associated with a median survival of 26 months, compared to 14 months with chemotherapy alone, in patients with sarcoma metastatic to the lung.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: